GAMMA Investing’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
1,275
+57
+5% +$20.2K 0.02% 645
2026
Q1
$391K Buy
1,218
+98
+9% +$29.2K 0.02% 692
2025
Q4
$290K Buy
1,120
+154
+16% +$35.1K 0.01% 787
2025
Q3
$219K Buy
966
+86
+10% +$17.6K 0.01% 917
2025
Q2
$184K Buy
880
+175
+25% +$33.7K 0.01% 964
2025
Q1
$137K Sell
705
-211
-23% -$43.6K 0.01% 1004
2024
Q4
$207K Buy
916
+278
+44% +$62.1K 0.02% 673
2024
Q3
$133K Buy
638
+375
+143% +$75.4K 0.01% 821
2024
Q2
$49.5K Buy
263
+169
+180% +$31.3K 0.01% 1205
2024
Q1
$17.3K Buy
94
+39
+71% +$7.25K ﹤0.01% 1743
2023
Q4
$10.2K Buy
+55
New +$9.53K ﹤0.01% 1893

Other funds holding MSGS

GAMMA Investing's MSGS Position: Q2 2026 in Review

GAMMA Investing increased its Madison Square Garden (MSGS) stake by 4.7% in Q2 2026, buying an estimated $20.2K and bringing the position to 1,275 shares worth $512K. The position accounts for 0.02% of the portfolio, ranked #645.

GAMMA Investing first reported a position in MSGS in Q4 2023 and has held it in 11 quarters since. 53 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • GAMMA Investing held 1,275 shares of Madison Square Garden worth $512K as of Q2 2026.
  • GAMMA Investing bought 57 Madison Square Garden shares in Q2 2026, an estimated $20.2K.
  • Madison Square Garden made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #645 holding.
  • GAMMA Investing first reported a position in Madison Square Garden in Q4 2023 and has held it in 11 quarters since.
  • 53 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.